FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: MedReleaf Corp

  • Home
  •  | 
  • Tag Archives: "MedReleaf Corp"

MedReleaf receives EU GMP certification for shipment from its Markham facility and completes first export to Cannamedical Pharma in Germany

MedReleaf receives EU GMP certification for shipment from its Markham facility and completes first export to Cannamedical Pharma in Germany
MedReleaf Corp. (TSX:LEAF) (OTC: MEDFF) today announced that it has received certification under the European Medical Agency's Good Manufacturing Practices ("EU GMP") Standards for its Markham facility from authorities in Cologne, Germany to make a first export of its products into Germany and has completed its first shipment of medical cannabis to Cannamedical Pharma GmbH ("Cannamedical").
Read more

The Largest Pot Stock in the World Is Moving to the NYSE

The Largest Pot Stock in the World Is Moving to the NYSE
Opening the door to legal marijuana sales should allow the Canadian pot industry to add approximately $5 billion in annual sales, when ramped up. This will come atop the revenue already being realized from medical cannabis sales and via exports to medical marijuana-legal foreign countries.
Read more

MedReleaf’s Analyst Ratings and Price Target

MedReleaf’s Analyst Ratings and Price Target
MedReleaf Corp (LEAF) has a market capitalization of about 1.8 billion Canadian dollars. Unlike Canopy Growth (WEED), Aphria (APHQF), and Aurora Cannabis (ACBFF), which have been around for a while, MedReleaf came out with its IPO in June 2017 at a price of 9.50 Canadian dollars.
Read more